Literature DB >> 1675752

Epstein-Barr virus latent genes in tumour cells of Hodgkin's disease.

L S Young, E M Deacon, M Rowe, J Crocker, H Herbst, G Niedobitek, S J Hamilton-Dutoit, G Pallesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1675752     DOI： 10.1016/0140-6736(91)93322-z

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Absence of HLA class I expression by Reed-Sternberg cells.

Authors:  S Poppema; L Visser
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

2.  Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.

Authors:  Eun Kyung Lee; Ji Hye Chae; Myung-Soo Kang
Journal:  Mol Cells       Date:  2011-10-19       Impact factor: 5.034

3.  Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.

Authors:  Wei Yue; Matthew G Davenport; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010.

Authors:  Gulfaraz Khan; Muhammad Jawad Hashim
Journal:  Infect Agent Cancer       Date:  2014-11-17       Impact factor: 2.965

5.  Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.

Authors:  Atif Ali Hashmi; Zubaida Fida Hussain; Kashif Ali Hashmi; Muhammad Irfan Zafar; Muhammad Muzzammil Edhi; Naveen Faridi; Mehmood Khan
Journal:  World J Surg Oncol       Date:  2017-04-20       Impact factor: 2.754

6.  Clinical silence of pulmonary lymphoepithelioma-like carcinoma with subcutaneous metastasis: a case report.

Authors:  Takafumi Shima; Kohei Taniguchi; Yasutsugu Kobayashi; Shotaro Kakimoto; Nagahisa Fujio; Kazuhisa Uchiyama
Journal:  World J Surg Oncol       Date:  2019-07-24       Impact factor: 2.754
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.